Basophil activation test in diagnosis of immediate hypersensitivity reactions to IL-17A inhibitors

J Eur Acad Dermatol Venereol. 2024 May;38(5):e404-e406. doi: 10.1111/jdv.19631. Epub 2023 Nov 27.

Authors

Qing Zhao^{1

2}, Tingting Liu^{1

2}, Lele Sun^{1

2}, Monday Ogaba Ogese³, Guoyan Liu^{1

2}, Hong Liu^{1

2}, Furen Zhang^{1

2

4}

Affiliations

¹ Hospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
² Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Jinan, Shandong, China.
³ Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.
⁴ Shandong University of Traditional Chinese Medicine, Jinan, China.

PMID: 38010028
DOI: 10.1111/jdv.19631

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Basophil Degranulation Test
Basophils / immunology
Drug Hypersensitivity / diagnosis
Drug Hypersensitivity / etiology
Female
Humans
Hypersensitivity, Immediate / chemically induced
Hypersensitivity, Immediate / diagnosis
Interleukin-17* / antagonists & inhibitors
Male
Middle Aged

Substances

Interleukin-17
Antibodies, Monoclonal, Humanized
IL17A protein, human
ixekizumab

Grants and funding